Top

Osteoporosis International

Published in:

01-05-2017 | Letter

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments

Authors: M. Kamimura, Y. Nakamura, S. Ikegami, S. Uchiyama, H. Kato, A. Taguchi

Published in: Osteoporosis International | Issue 5/2017

Excerpt

Dear Editor, …

Fu S, Sheng Z (2017) Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients. Osteoporos Int. doi:10.1007/s00198-017-3923-5

Kamimura M, Nakamura Y, Ikegami S, Uchiyama S, Kato H, Taguchi A (2016) Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients. Osteoporos Int. doi:10.1007/s00198-016-3764-7 PubMedPubMedCentral

Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:1910CrossRefPubMed

Adler RA (2016) Bisphosphonates and atypical femoral fractures. Curr Opin Endocrinol Diabetes Obes 23:430–434CrossRefPubMed

Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189–1199CrossRefPubMed

Ishtiaq S, Fogelman I, Hampson G (2015) Treatment of post-menopausal osteoporosis: beyond bisphosphonates. J Endocrinol Investig 38:13–29CrossRef

Cummings SR, Cosman F, Lewiecki EM, Schousboe JT, Bauer D, Black D, Brown T, Cheung AM, Cody K, Cooper C, Diez-Perez A, Eastell R, Hadji P, Hosoi T, De Beur SJ, Kagan R, Kiel DP, Reid I, Solomon DH, Randall S (2016) Goal-directed treatment for osteoporosis: a progress report from the ASBMR-NOF working group on goal-directed treatment for osteoporosis. J Bone Miner Res. 19. [Epub ahead of print] Review

Khan AA, Morrison A, Hanley DA, Felsenberg D, LK MC, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23CrossRefPubMed

Khan AA, Morrison A, Kendler DL, Rizzoli R, Hanley DA, Felsenberg D, McCauley LK, Oryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Dabagh RA, Davison KS, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J; (2016) Case-based review of osteonecrosis of the Jaw (ONJ) and application of the international recommendations for management from the International Task Force on ONJ. J Clin Densitom. 2016; S1094–6950 30196–2

10.

Taguchi A, Kamimura M, Nakamura Y, Sugino N, Ichinose A, Maezumi H, Fukuzawa T, Ashizawa R, Takahara K, Gushiken S, Mukaiyama K, Ikegami S, Uchiyama S, Kato H (2016) Delayed wound healing after tooth extraction and self-reported kyphosis in Japanese men and women. Sci Rep. 6:36309

11.

Taguchi A, Shiraki M, Sugimoto T, Ohta H, Soen S (2016) Japan Osteoporosis Society. Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw. Curr Med Res Opin 32:1261–1268CrossRefPubMed

Title: Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments
Authors: M. Kamimura
Y. Nakamura
S. Ikegami
S. Uchiyama
H. Kato
A. Taguchi
Publication date: 01-05-2017
Publisher: Springer London
Published in: Osteoporosis International / Issue 5/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-017-3923-5

2024 ASCO Annual Meeting

Springer Medicine

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2017

Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities

Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan

Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?

Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation

Use of proton pump inhibitors and mortality after hip fracture in a nationwide study

Standardizing 25-hydroxyvitamin D data from the HunMen cohort